Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Armakolas

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Medicine|September 30, 2009
Differences in gene expression between individuals with multiple primary and single primary malignanciesG P Stathopoulos, A Armakolas
Current Opinion in Cell Biology|December 22, 2009
Discovery of the mitotic selective chromatid segregation phenomenon and its implications for vertebrate developmentA Armakolas, M Koutsilieris, A J S Klar
Oncology Letters|September 12, 2012
Plasma VEGF levels in breast cancer patients with and without metastasesJ Stathopoulos, A Armakolas, G P Stathopoulos, et al.
Oncology Reports|March 25, 2011
Granulocyte colony-stimulating factor expression as a prognostic biomarker in non-small cell lung cancerG P Stathopoulos, A Armakolas, T Tranga, et al.
Oncology|August 28, 2010
Treatment of colorectal cancer with and without bevacizumab: a phase III studyG P Stathopoulos, C Batziou, D Trafalis, et al.
The American Journal of Gastroenterology|April 14, 2000
Prognostic significance of circulating antibodies against carcinoembryonic antigen (anti-CEA) in patients with colon cancerK Albanopoulos, A Armakolas, M M Konstadoulakis, et al.
Clinical Genetics|March 1, 2005
Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals--correlation with clinicopathological dataA Kataki, Ip Gomatos, N Pararas, et al.
Molecular Medicine (Cambridge, Mass.)|August 24, 2018
IL-6 is associated to IGF-1Ec upregulation and Ec peptide secretion, from prostate tumorsA Armakolas, A Dimakakos, C Loukogiannaki, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Medicine|September 30, 2009
Differences in gene expression between individuals with multiple primary and single primary malignanciesG P Stathopoulos, A Armakolas
Current Opinion in Cell Biology|December 22, 2009
Discovery of the mitotic selective chromatid segregation phenomenon and its implications for vertebrate developmentA Armakolas, M Koutsilieris, A J S Klar
Oncology Letters|September 12, 2012
Plasma VEGF levels in breast cancer patients with and without metastasesJ Stathopoulos, A Armakolas, G P Stathopoulos, et al.
Oncology Reports|March 25, 2011
Granulocyte colony-stimulating factor expression as a prognostic biomarker in non-small cell lung cancerG P Stathopoulos, A Armakolas, T Tranga, et al.
Oncology|August 28, 2010
Treatment of colorectal cancer with and without bevacizumab: a phase III studyG P Stathopoulos, C Batziou, D Trafalis, et al.
The American Journal of Gastroenterology|April 14, 2000
Prognostic significance of circulating antibodies against carcinoembryonic antigen (anti-CEA) in patients with colon cancerK Albanopoulos, A Armakolas, M M Konstadoulakis, et al.
Clinical Genetics|March 1, 2005
Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals--correlation with clinicopathological dataA Kataki, Ip Gomatos, N Pararas, et al.
Molecular Medicine (Cambridge, Mass.)|August 24, 2018
IL-6 is associated to IGF-1Ec upregulation and Ec peptide secretion, from prostate tumorsA Armakolas, A Dimakakos, C Loukogiannaki, et al.
Pageof 1